The Bioanalytical Core will serve all projects in this Program. It will consist of an Analytical component (directed by Dr. Blair-Center for Cancer Pharmacology, University of Pennsylvania), and a Synthetic component (directed by Dr. Harvey-The Ben May Institute, University of Chicago). The major roles of the Analytical component are: 1) to assess the purity of PAHmetabolites used by all Project Investigators (Projects 1-3), and this is pertinent to the use of anti- and syn-diol epoxides which hydrolyze to tetraols; 2) to quantitate PAH-metabolites formed in cell culture experiments, once structural validation of the analyte has been achieved; 3) to quantitate concentrations of PAH-o-quinones used in cell culture experiments, once structural validation of the analyte has been achieved; 4) to quantitate covalent modifications to DNA by PAH-metabolites and reactive oxygen species in Project 1 once methods development and validation has been achieved in Project 2; and 5) with support from the Administrative Core A to act as a liaison between the NCI Chemical Carcinogen Reference Standard Repository and Project Investigators to maintain stocks of individual PAH-metabolites and PAH-synthons. The analytical component will be reliant on a PAH-Database and a Program Database maintained in the Administrative Core-A these will monitor stocks of PAH-metabolites and perform statistical analysis of PAH-DNA adducts. The Analytical component of Core B contains a triple-quadruple mass spectrometer and an ion-trap mass spectrometer. The Synthetic component of Core B will develop efficient synthetic strategies to: 1) the major stable benzo[a]pyrene diol-epoxide (BPDE) adducts [(+) and (-)-anti-BPDE-N6-dAdo (trans-isomers); (+) and (-)-anti-BPDE-N6 dAdo (cis-isomers), (+) and (-) anti-BPDE-N2-dGuo (trans-isomers) (+)-and (-)-anti-BPDE-N2-dGuo (cisisomers)], major radical-cation BP depurination adducts [N7- and C8-guanine and N7-adenine adducts of BP], and the stable and depurinating adducts of BP-2 7,8-dione [N -dGuo, N6-dAdo, N7-guanine and N7-adenine]. These reference standards will be used in Projects 1 and 2 to identify unknowns; and 2) to develop synthetic strategies to the stable and depurinating adducts of BA-3,4- dione [N2-dGuo, N6-dAdo, N7-guanine and N7-adenine] and the stable and depurinating adducts of DMBA-3,4-dione [N2-dGuo, N6-dAdo, N7-guanine and N7- adenine] for their detection in cell culture paradigms in collaboration with Project 1. Via Core A, we will inform the Repository of the availability of novel PAH-DNA adducts for distribution to the PAH-research community. This will establish a symbiotic relationship between Core B and the Repository. Thus, Core B is a vital component to the success of all Projects of the PPG and may impact PAH-DNA adduct research in general.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Program Projects (P01)
Project #
1P01CA092537-01A1
Application #
6673741
Study Section
Subcommittee E - Prevention &Control (NCI)
Project Start
2002-08-30
Project End
2007-07-31
Budget Start
Budget End
Support Year
1
Fiscal Year
2002
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Shultz, Carol A; Quinn, Amy M; Park, Jong-Heum et al. (2011) Specificity of human aldo-keto reductases, NAD(P)H:quinone oxidoreductase, and carbonyl reductases to redox-cycle polycyclic aromatic hydrocarbon diones and 4-hydroxyequilenin-o-quinone. Chem Res Toxicol 24:2153-66
Xu, Daiwang; Penning, Trevor M; Blair, Ian A et al. (2009) Synthesis of phenol and quinone metabolites of benzo[a]pyrene, a carcinogenic component of tobacco smoke implicated in lung cancer. J Org Chem 74:597-604
Oliva, Jose L; Caino, M Cecilia; Senderowicz, Adrian M et al. (2008) S-Phase-specific activation of PKC alpha induces senescence in non-small cell lung cancer cells. J Biol Chem 283:5466-76
Xu, Daiwang; Duan, Yazhen; Blair, Ian A et al. (2008) Synthesis of dibenzo[def,p]chrysene, its active metabolites, and their 13C-labeled analogues. Org Lett 10:1059-62
Park, Jong-Heum; Gelhaus, Stacy; Vedantam, Srilakshmi et al. (2008) The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominance. Chem Res Toxicol 21:1039-49
Quinn, Amy M; Penning, Trevor M (2008) Comparisons of (+/-)-benzo[a]pyrene-trans-7,8-dihydrodiol activation by human cytochrome P450 and aldo-keto reductase enzymes: effect of redox state and expression levels. Chem Res Toxicol 21:1086-94
Shultz, Carol A; Palackal, Nisha T; Mangal, Dipti et al. (2008) Fjord-region benzo[g]chrysene-11,12-dihydrodiol and benzo[c]phenanthrene-3,4-dihydrodiol as substrates for rat liver dihydrodiol dehydrogenase (AKR1C9): structural basis for stereochemical preference. Chem Res Toxicol 21:668-77
Ran, Chongzhao; Dai, Qing; Ruan, Qian et al. (2008) Strategies for synthesis of adducts of omicron-quinone metabolites of carcinogenic polycyclic aromatic hydrocarbons with 2'-deoxyribonucleosides. J Org Chem 73:992-1003
Jiang, Hao; Gelhaus, Stacy L; Mangal, Dipti et al. (2007) Metabolism of benzo[a]pyrene in human bronchoalveolar H358 cells using liquid chromatography-mass spectrometry. Chem Res Toxicol 20:1331-41
Dai, Qing; Xu, Daiwang; Lim, Keunpoong et al. (2007) Efficient syntheses of C(8)-aryl adducts of adenine and guanine formed by reaction of radical cation metabolites of carcinogenic polycyclic aromatic hydrocarbons with DNA. J Org Chem 72:4856-63

Showing the most recent 10 out of 29 publications